After more than two consecutive years of stunning growth, Nvidia has run up against tough comps. The company's technology is at the heart of the AI revolution, but some fear the low-hanging fruit has been picked.

Investing in an industry-specific ETF can make it easier to gain exposure to the tech sector without choosing individual stocks. Compared to some other investments, this particular ETF helps balance risk and reward.

Oracle is forecasting a significant acceleration in growth through 2030, owing to the terrific demand for its cloud infrastructure. Importantly, Oracle seems to have a big-enough contract backlog that should allow it to achieve its goals.

Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases Advances the Novartis xRNA strategy by adding a scientifically robust, muscle-directed, Antibody Oligonucleotide Conjugates (AOCs™) platform and first-in-disease pipeline Expected to unlock multi-billion-dollar opportunities with planned product launches before 2030 Raises expected 2024-2029 sales CAGR for Novartis from +5% to +6%, and bolsters mid-single digit long-term growth As part of the agreement, Avidity will separate its early-stage precision cardiology programs into a new company (“SpinCo”) prior to closing Consideration totals USD 12bn in cash; closing expected in …

The International Association of Machinists and Aerospace Workers union said on Sunday it voted to reject Boeing's latest contract offer, saying the company had failed to address the core priorities of its skilled and dedicated workforce.

Chevron and the Trump administration are aligned in their values that see American energy dominance as linked to "economic competitiveness," CEO Mike Wirth says.

Sold 279,026 Mercury Systems shares; estimated transaction value of $17.35 million, based on the quarterly average price for Q3 2025 Post-trade position: 2,279,909 shares valued at $176.46 million as of the third quarter Mercury Systems stake now represents 2.83% of fund AUM, outside the top five holdings

Energy Transfer's extensive midstream operations generate lots of cash. It's using that money to pay for its lucrative distribution and expand its operations.

NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially misleading business information to the investing public.

NEW YORK , Oct. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fortinet, Inc. (NASDAQ: FTNT) between November 8, 2024 and August 6, 2025, both dates inclusive (the "Class Period"), of the important November 21, 2025 lead plaintiff deadline. So what: If you purchased Fortinet common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Price increases drove most of the company's yearly revenue growth in Q3. Coca-Cola's valuation is below the S&P 500 average.

Swiss pharmaceutical giant Novartis is nearing a deal to buy biotechnology company Avidity Biosciences for more than $70 a share, Bloomberg News reported.

Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue.

Scott Bessent said plan was part of framework for trade deal but did not share details on transferring app's ownership

As the stock market hits new highs, equities in cryptocurrency mining and data center infrastructure are emerging as some of 2025's biggest winners.

Wall Street analysts are inherently cautious; they usually prefer to play it safe to safeguard their careers and reputation. In the homebuilding segment of real estate, these analysts adopted a bearish outlook, lowering price targets for major U.S. builders.

Medtronic's shares have sharply rallied over the last six months. The medtech giant's growth catalysts include a best-in-class product (Affera) in a fast-growing $11 billion space and a massive opportunity in the underpenetrated urge urinary incontinence market. Medtronic possesses an A S&P credit rating with a stable outlook.

Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares valued at $164.06 million as of September 30, 2025 The Exponent position accounted for 2.63% of fund AUM after the sale in the third quarter of 2025

Multiple short-seller reports have come out within the past year about AppLovin. The SEC has recently begun a probe into the company's data collection practices.

Cameco, operating largely in politically stable regions, is a large producer of uranium. Uranium demand is projected to outstrip supply starting around 2030 -- a bullish sign.